Information Provided By: 
Fly News Breaks for January 8, 2018
WMGI
Jan 8, 2018 | 09:20 EDT
Piper Jaffray analyst Matt O'Brien recommends investors purchase shares of Wright Medical following this morning's preliminary Q4 results. Wright reported preliminary Q4 revenue that beat consensus estimates, and importantly, 2017 sales came in at the high end of previously provided guidance range, O'Brien tells investors in a research note. The analyst sees a "solid set-up" for 2018 and keeps an Overweight rating on Wright Medical with a $32 price target.
News For WMGI From the Last 2 Days
There are no results for your query WMGI
